Related Articles
Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma
Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma